M
Matthew Arentz
Researcher at University of Washington
Publications - 17
Citations - 1679
Matthew Arentz is an academic researcher from University of Washington. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 8, co-authored 13 publications receiving 1563 citations. Previous affiliations of Matthew Arentz include Pennsylvania State University & University of Washington Medical Center.
Papers
More filters
Journal ArticleDOI
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Dennis Falzon,Ernesto Jaramillo,Holger J. Schünemann,Matthew Arentz,Melissa Bauer,Jaime Bayona,Léopold Blanc,Jose A. Caminero,Charles L. Daley,Chris Duncombe,Christopher Fitzpatrick,Agnes Gebhard,Haileyesus Getahun,Myriam Henkens,Timothy H. Holtz,J. Keravec,S. Keshavjee,Aamir J. Khan,R. Kulier,Vaira Leimane,Christian Lienhardt,Chunling Lu,Mar'iandyshev Ao,Giovanni Battista Migliori,Fuad Mirzayev,Carole D. Mitnick,Paul Nunn,G. Nwagboniwe,Olivia Oxlade,Domingo Palmero,Patricia B Pavlinac,M. I. D. Quelapio,Mario C. Raviglione,Michael Rich,S. Royce,Sabine Rüsch-Gerdes,A. Salakaia,R. Sarin,Delphine Sculier,Francis Varaine,Marco Vitoria,Judd L. Walson,Fraser Wares,Karin Weyer,Richard A. White,Matteo Zignol +45 more
TL;DR: The guidelines promote the early use of antiretroviral agents for TB patients with HIV on second-line drug regimens and systems that primarily employ ambulatory models of care are recommended over others based mainly on hospitalisation.
Journal ArticleDOI
Salivary testosterone determination in studies of child health and development.
TL;DR: This laboratory has developed a reliable, efficient, and highly sensitive procedure for measuring testosterone in children's saliva that does not require separation or extraction and can be easily applied to the investigation of testosterone-behavior relations in the context of studies on child health and development.
Journal ArticleDOI
Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs
David J. Horne,Lancelot Pinto,Matthew Arentz,S.-Y. Grace Lin,Edward Desmond,Laura L. Flores,Karen R Steingart,Jessica Minion +7 more
TL;DR: A systematic review and meta-analysis of the diagnostic accuracy and reproducibility of phenotypic DST for first-line and second-line antituberculosis drugs provides support for recommended critical concentrations for isoniazid and rifampin in commercial broth-based systems.
Journal ArticleDOI
Association between Smoking and Latent Tuberculosis in the U.S. Population: An Analysis of the National Health and Nutrition Examination Survey
David J. Horne,Monica Campo,Justin R. Ortiz,Eyal Oren,Eyal Oren,Matthew Arentz,Kristina Crothers,Masahiro Narita,Masahiro Narita +8 more
TL;DR: In the large, representative, population-based NHANES sample, smoking was independently associated with significantly increased risks ofLTBI and in certain populations, a greater risk of LTBI corresponded with increased smoking exposure.
Journal ArticleDOI
Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis
TL;DR: Rapid tests for rifampicin resistance alone cannot accurately predict rifametricin resistance or MDR-TB in areas with a low prevalence of rifampsicin Resistance, however, in areas of the world with a high prevalence of the latter these tests may be a valuable component of an M DR-TB management strategy.